Newhouse, United Kingdom

Paul David Ratcliffe



 

Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • Newhouse, GB (2010 - 2014)
  • Aarcher, DE (2015 - 2016)
  • Strathaven, GB (2016 - 2017)

Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: The Innovative Mind of Paul David Ratcliffe

Introduction

Paul David Ratcliffe is a prolific inventor based in Newhouse, Great Britain, known for his significant contributions in the field of pharmacology. With an impressive portfolio of 10 patents, Ratcliffe has focused on developing compounds that play a crucial role in health care, particularly in the modulation of aldosterone synthase.

Latest Patents

Among his latest innovations, Ratcliffe has developed two notable patents:

1. **Pyrazolopyridyl Compounds as Aldosterone Synthase Inhibitors**: This patent relates to a specific class of pyrazolopyridyl compounds that selectively inhibit aldosterone synthase. The invention includes pharmaceutical compositions that consist of these compounds or their salts, offering potential methods for treating conditions that may be addressed by inhibiting aldosterone synthase.

2. **Triazolopyridyl Compounds as Aldosterone Synthase Inhibitors**: Similar to his earlier work, this patent involves triazolopyridyl compounds designed to selectively inhibit aldosterone synthase. It also pertains to pharmaceutical compositions containing these compounds or their salts and outlines methods that could be used for the treatment, amelioration, or prevention of related medical conditions.

Career Highlights

Ratcliffe has had a distinguished career, having worked with leading pharmaceutical companies such as Merck Sharp & Dohme Corporation and N.V. Organon. His experience in these organizations has allowed him to refine his skills in drug development and invention.

Collaborations

Throughout his career, Paul David Ratcliffe has collaborated with esteemed colleagues, including Scott B. Hoyt and Clare London. These partnerships have resulted in innovative approaches and advancements within the pharmaceutical field.

Conclusion

Paul David Ratcliffe’s inventive prowess and dedication to science continue to have a lasting impact in the pharmaceutical industry. His work on compounds that target aldosterone synthase is paving the way for new therapeutic options, demonstrating the importance of innovation in healthcare. With a portfolio that boasts significant patents, Ratcliffe is surely a name to watch in the realm of medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…